Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-04), Clearside Biomedical's 3-1 Month Momentum % is N/A%.
The industry rank for Clearside Biomedical's 3-1 Month Momentum % or its related term are showing as below:
STU:CLM0's 3-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: -5.77 * Ranked among companies with meaningful 3-1 Month Momentum % only.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Clearside Biomedical 3-1 Month Momentum % Related Terms
STU:CLM0 vs CDT, BPTH, ABPO: 3-1 Month Momentum % Comparison
For the Biotechnology subindustry, Clearside Biomedical's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clearside Biomedical 3-1 Month Momentum % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Clearside Biomedical's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Clearside Biomedical's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clearside Biomedical (STU:CLM0) has a 3-1 Month Momentum % of N/A% as of Sep. 04, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clearside Biomedical and its competitors. According to the industry distribution chart, Clearside Biomedical ranks #1143 out of 1387 companies in the Biotechnology industry, placing it in the top 82.4%.
Is Clearside Biomedical's 3-1 Month Momentum % too high?
Clearside Biomedical's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Clearside Biomedical ranks #1143 out of 1387 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Clearside Biomedical has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Clearside Biomedical's 3-1 Month Momentum % compare to CDT and BPTH?
According to the Biotechnology industry distribution chart, Clearside Biomedical ranks #1143 out of 1387 companies for 3-1 Month Momentum %. This places Clearside Biomedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clearside Biomedical and its competitors. Clearside Biomedical's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearside Biomedical stock overvalued right now?
Clearside Biomedical (STU:CLM0) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is €108.14, compared to a current price of €4.35 — trading 96% below its estimated fair value. The current 3-1 Month Momentum % is N/A%. Clearside Biomedical's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Clearside Biomedical (STU:CLM0), the current 3-1 Month Momentum % is N/A% as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clearside Biomedical (STU:CLM0) Overvalued in 2026?
Based on GuruFocus' analysis, Clearside Biomedical stock appears to be undervalued.
The current stock price of €4.35 is trading 96% below its estimated GF Value™ of €108.14.
Key valuation signals for STU:CLM0:
3-1 Month Momentum %: N/A%
GF Value™: €108.14 vs. price of €4.35 (96% below fair value)
No single metric tells the full story. See the STU:CLM0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
44GF Score
Get the complete analysis for STU:CLM0
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:CLM0 has been successfully added to your 
